Join the 2012 business delegation to BIO
01 March, 2012 by AusBiotechAusBiotech invites you to take part in the BIO International Convention, the largest global event for the biotechnology industry, attracting the biggest names in biotech.
Sirtex Medical 1H profit climbs 70%
01 March, 2012 by Dylan Bushell-EmblingSirtex Medical (ASX:SRX) has reported a 69.7% increase in 1H profit, due in part to accelerating sales of its radioactive microsphere treatments for liver cancer.
Alchemia granted new US fondaparinux patent
01 March, 2012 by Dylan Bushell-EmblingAlchemia Limited (ASX:ACL) has been granted the second of four US patents it has applied for to protect its manufacturing process for the fondaparinux blood clot treatment.
LCT posts $8.1m 1H profit on JV deal
01 March, 2012 by Dylan Bushell-EmblingLiving Cell Technologies (ASX:LCT) swung to an $8.1m profit in 1H12, after selling its DIABECELL assets to its new 50/50 joint venture.
Genetic Technologies reports $3.3m 1H loss
29 February, 2012 by Dylan Bushell-EmblingGenetic Technologies (ASX:GTG) has reported a $3.3m loss for 1H12, as a result of declining diagnostics and patent licensing revenue.
Coridon developing next-gen HPV vaccine
29 February, 2012 by Dylan Bushell-EmblingIan Frazer and the team at Coridon is working on a new vaccine that will also provide treatment for human papillomavirus (HPV) in infected women.
Patent reform bill passes Senate
28 February, 2012 by Tim DeanThe Raising the Bar bill, which tightens Australian patent laws, including adding an exemption for researchers, has cleared the Senate and will move to the House of Representatives.
Partner & exhibitor packages now open for AusBiotech 2012
28 February, 2012 by AusBiotechPartnership and exhibition packages are now available for the AusBiotech 2012 national conference to be held in Melbourne, Victoria from 30 October to 2 November 2012.
Phylogica wins US peptide patent
27 February, 2012 by Dylan Bushell-EmblingPerth-based Phylogica (ASX:PYC) has received a US patent for one of its Phylomer library of peptides with potential drug development leads.
Working group on promotion of therapeutic products
23 February, 2012 by AusBiotechKey industry stakeholders have been debating whether or not companies should prescribe to a harmonised code of conduct to achieve TGA registration.
Start-up Vitality signs APAC distribution deals
22 February, 2012 by Dylan Bushell-EmblingVitality Devices, a new Australian company founded to commercialise medical devices in Asia-Pacific, has signed its first two distribution deals.
Gene patents challenged in court
22 February, 2012 by Dylan Bushell-EmblingIn the middle of the patent fight over the BRCA1 gene mutation, Genetic Technologies (ASX:GTG) announced a new settlement in the rash of infringement suits covering its non-coding DNA patent.
AusBiotech international investment showcase events in Hong Kong and New York
21 February, 2012 by AusBiotechAusBiotech is calling for expressions of interest to participate in two international showcase events in Hong Kong and New York.
Genetic Technologies gains access to full US market for BREVAGen
17 February, 2012 by Dylan Bushell-EmblingGenetic Technologies' (ASX:GTG) Victorian lab has received US certification that will enable it to launch its BREVAGen cancer test in all 50 US states.
Bionomics seeks patent for Alzheimer's treatment
17 February, 2012 by Dylan Bushell-EmblingSouth Australia's Bionomics (ASX:BNO) is pursuing an international patent application for a method of improving memory in patients with Alzheimer's and other neurodegenerative diseases.
